Medical research

Long-lasting device protects against HIV and pregnancy

Women's reproductive health may never be the same, thanks to Northwestern University biomedical engineer Patrick Kiser and his first-of-its-kind intravaginal ring that reliably delivers an antiretroviral drug and a contraceptive ...

HIV & AIDS

Combination approach reduces spread of drug-related HIV

A computer model has created the most effective formula for reducing the spread of HIV among drug users in New York City over the next 25 years. Developed by scientists at Columbia University's Mailman School of Public Health ...

HIV & AIDS

Unusual new HIV drug resistance mechanism revealed

For the more than one million people with HIV/AIDS in the United States (and the over 34 million people living with HIV/AIDS around the world), antiretroviral drugs such as efavirenz and other so-called non-nucleoside reverse ...

HIV & AIDS

HIV/AIDS prevalence and prospects

In the more than two decades that psychology professor Seth Kalichman has devoted to HIV/AIDS prevention, he has seen the public health landscape change dramatically. This is what he had hoped for when, as a graduate student ...

HIV & AIDS

Monoclonal antibodies show promise as effective HIV therapy

A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. Published on-line ...

HIV & AIDS

HIV infections plummet since 2001: UN

New HIV infections have plummeted by a third overall since 2001 and more than halved among children, the United Nations said Monday.

HIV & AIDS

New drug approved to treat HIV-1

(HealthDay)—Tivicay (dolutegravir) has been approved by the U.S. Food and Drug Administration to treat infection with HIV-1, a strain of the virus that causes AIDS.

page 12 from 24